Adjuvant and salvage treatment after radical prostatectomy: current practice in the UK.
AffiliationClinical Oncology, Christie Hospital, Manchester, UK.
MetadataShow full item record
AbstractOBJECTIVE: To survey UK urologists and radiation oncologists in the evaluation and treatment of localised prostate cancer in the adjuvant and salvage setting. METHODS: Postal questionnaires were mailed to 292 urologists and 98 radiation oncologists in the UK. RESULTS: In all, 188 (48%) questionnaires were returned. In total, 72/128 (56%) of the urologist respondents and 58/60 (97%) of the oncologist respondents perform routine radical prostate treatment. Among 43 (60%) of the urologist, 40 (69%) recommended adjuvant treatment, which could be radiotherapy, hormonal treatment or combined hormonal and radiation treatment. There is no significant difference between the modality of treatment recommended. The poor prognostic factors that would influence the decision to offer adjuvant treatment include a detectable postoperative PSA, seminal vesicle involvement, positive margins, Gleason score>8 and pathological T3. With regard to the choice of hormonal treatment, most urologists preferred antiandrogens, whereas most oncologists prefer lutienising hormone releasing hormone (LHRH) analogue (P=0.03). Regarding salvage treatment, there is a wide variation in the PSA threshold and number of PSA rises before initiation of investigations and treatment. Significantly more urologists recommended salvage radiotherapy (P=0.02), whereas oncologists recommended combined hormonal radiation therapy (P=0.03). There is a wide variation of practice regarding the duration of hormonal treatment, the type of investigations initiated, range of radiotherapy doses and treatment volumes. CONCLUSION: There is a wide variation in practice among UK clinicians.
CitationAdjuvant and salvage treatment after radical prostatectomy: current practice in the UK. 2005, 8 (3):229-34 Prostate Cancer Prostatic Dis.
JournalProstate Cancer and Prostatic Diseases
- Radiotherapy after radical prostatectomy: treatment recommendations differ between urologists and radiation oncologists.
- Authors: Lavallée LT, Fergusson D, Mallick R, Grenon R, Morgan SC, Momoli F, Witiuk K, Morash C, Cagiannos I, Breau RH
- Issue date: 2013
- Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
- Authors: Ploussard G, Agamy MA, Alenda O, Allory Y, Mouracade P, Vordos D, Hoznek A, Abbou CC, de la Taille A, Salomon L
- Issue date: 2011 Jun
- Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features.
- Authors: Vargas C, Kestin LL, Weed DW, Krauss D, Vicini FA, Martinez AA
- Issue date: 2005 Mar 1
- Variation in treatment recommendations of adjuvant radiation therapy for high-risk prostate cancer by physician specialty.
- Authors: Kim SP, Tilburt JC, Karnes RJ, Ziegenfuss JY, Han LC, Shah ND, Frank I, Smaldone MC, Gross CP, Yu JB, Trinh QD, Sun M, O'Malley RL, Nguyen PL
- Issue date: 2013 Oct
- Current opinion on adjuvant and salvage treatment after radical prostatectomy.
- Authors: Morris SL, Parker C, Huddart R, Horwich A, Dearnaley D
- Issue date: 2004 Jun